Is catheter-directed foam sclerotherapy more effective than the usual foam sclerotherapy for treatment of the great saphenous vein?

Abstract

Objective

This retrospective study presents the long-term results of catheter-directed foam sclerotherapy of the great saphenous vein.

Method

From January 2003 to June 2017, 277 patients with varices and great saphenous vein incompetence were treated with echo-guided foam sclerotherapy. Forty-six patients were treated with long-catheters guided by foam sclerotherapy. Foaming was carried out with sodium-tetra-decyl-sulphate.

Results

Results were examined in the two groups: A (long-catheters) and B (other procedures). The median overall follow-up was 52.1 months. In the A-group, the complete occlusion rate was 34/46 pts (73.9%) and partial occlusion was 10/46 (21.7%). In the B-group, respectively, 130/231 (56.2%) and 90/231 (38.9%). Comparisons between groups were statistically significant (p = 0.023; p = 0.021). Failures involved, respectively, 2/46 (4.3%) and 11/231 (4.7%) with no statistical significance. The complication rates were similar in the two groups.

Conclusions

In this long-term experience (median follow-up exceeding four years), foam-guided sclerotherapy of the great saphenous vein with a long-catheter turned out to be more effective than the usual foam-guided sclerotherapy.

Keywords

Foam sclerotherapy great saphenous vein ultrasound-guided sclerotherapy varicose veins

Get full access to this article

View all access options for this article.

References

Tessari

. Nouvelle technique d’obtention del la sclero-mousse. Phlebologie 2000; 53: 129–129.

Gloviczki

Comerota

Dalsing

. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and American Venous Forum. J Vasc Surg 2011; 53: 2S–48S.

National Institute for Health and Care Excellence (NICE). Varicose veins in the legs. The diagnosis and management of varicose veins. Manchester: NICE, 2013. Available at www.nice.org.uk/guidance/cg168.

Orsini

Brotto

. Immediate patholocic effects on the vein wall of foam sclerotherapy. Dermatol Surg 2007; 33: 1–5.

Parsi

. Catheter-directed sclerotherapy. Phlebology 2009; 24: 98–107.

Robert

. La sclerose par echo-catheterisme. Phlebologie 1995; 48: 13–16.

Milleret

Garandeau

Brel

et al.

Foam sclerotherapy of the great saphenous veins via ultrasound-guided catheter in an empty vein: the alpha-technique. Phlebologie 2004; 57: 15–18.

Brodersen

Geismar

. Catheter assisted vein sclerotherapy: a new approach for sclerotherapy of the great saphenous vein with a double-lumen balloon catheter. Dermatol Surg 2007; 33: 469–475.

Bidwai

Beresford

Dyalinas

et al.

Balloon control of the saphenofemoral junction during foam sclerotherapy: proposed innovation. J Vasc Surg 2007; 46: 145–147.

10.

Reich-Shupke

Altmeyer

Stucker

. Triple-lumen double-ballooncatheter for foam sclerotherapy of great saphenous vein: critical review on preliminary results. Phlebology 2010; 25: 241–245.

11.

Cavezzi

Tessari

. Foam sclerotherapy techniques: different gases and methods of preparation, catheter versus direct injection. Phlebology 2009; 24: 247–2451.

12.

Kurdal

Yildirim

Ozbakkaloglu

et al.

Ultrasound-guided catheter- directed foam sclerotherapy for great saphenous vein. Minerva Chir 2015; 70: 33–36.

13.

Ali

Elbadawy

Saleh

et al.

Mid- term results of catheter directed foam sclerotherapy combined with tumescent local anesthesia for treatment of great saphenous vein incompetence. Eur J Endovasc Surg 2017; 54: 363–368.

14.

Devereux

Recke

Westermann

et al.

Catheter- directed foam sclerotherapy of the great saphenous veins in combination with pre-treatment reduction of the diameter employing the principals of perivenous tumescent local anesthesia. Eur J Vasc Endovasc Surg 2014; 47: 187–195.

15.

Cavezzi

. Re: Catheter- directed foam sclerotherapy of the great saphenous veins in combination with pre-treatment reduction of the diameter employing the principals of perivenous tumescent local anesthesia. Eur J Vasc Endovasc Surg 2014; 48: 597–598.

16.

Cavezzi

Mosti

Campana

et al.

Catheter foam sclerotherapy of the great saphenous vein, with perisaphenous tumescence infiltration and saphenous irrigation. Eur J Endovasc Surg 2017; 54: 629–635.

17.

Jia

Morwatt

Burr

. Systematic review of foam sclerotherapy for varicose vein. Br J Surg 2007; 94: 925–936.

18.

Guex

Allaert

Gillet

et al.

Immediate and midterm complications of sclerotherapy: report of a prospective multicentre registry of 12.173 sclerotherapy sessions. Dermatol Surg 2005; 31: 123–128; discussion 128.

19.

Yiannakopoulou

. Safety concerns for sclerotherapy of telangiectases, reticular and varicose veins. Pharmacology 2016; 98: 62–69.

20.

Agus

Allegra

Arpaia

et al.

Malattia Venosa Cronica Linee guida revisione 2013. Acta Phlebol 2013; 14(Suppl. 1al n° 2): 1–160.

21.

Launois

Mansilha

Jantet

. International psychometric validation of the chronic venous disease quality of life questionnaire (CIVIQ-20). Eur J Vasc Endovasc Surg 2010; 40: 783–789.

22.

de Souza

Cyrino

Mayall

et al.

Beneficial effects of the micronized purified flavonoid (MPFF Daflon 500 mg) on microvascular damage elicited by sclerotherapy. Phlebology 2016; 31: 50–56.

23.

Brittenden

Cotton

Elders

et al.

Clinical effectiveness and cost-effectiveness of foam sclerotherapy, endovenous laser ablation and surgery for varicose veins: results from the Comparison of LAser, Surgery and foam Sclerotherapy (CLASS) randomised controlled trial. Health Technol Assess 2015; 19: 1–342.

24.

Venermo

Saarinen

Eskelinen

et al..; the Finnish Venous Study Collaborators. Randomized clinical trial comparing surgery, endovenous laser ablation and ultrasound-guided foam sclerotherapy for the treatment of the great saphenous varicose veins. BJS 2016; 103: 1438–1444.